Navigation Links
Two New Human Papilloma virus (HPV) vaccines to prevent cervical cancer

Cervical cancer is the second leading cause of female cancer mortality worldwide, with 288,000 deaths annually. About 510,000 cases are // reported each year, 80% of them in developing countries.

Two new vaccines are undergoing trial to prevent HPV infections, which causes cervical cancer. These vaccines must be given to girls before they are sexually active. The new vaccines are manufactured by GlaxoSmithkline against HPV 16 and 18 strains and the Merck Vaccine against HPV 16,18,6 and 11. These vaccines carry the L capsid protein and when given in 3 doses generate high levels of neutralizing antibodies.

Both the drugs are safe and show an efficacy of more than 90% in Phase I and II trials. These both vaccines are in their phase III trial and are expected to be in market in an other 2 years.

Studies are currently undergoing to find the duration and efficacy of the vaccine, its effect on menstrual cycle and the need for booster vaccine. Problems with the new vaccine are due to high cost, the dosages required are three injections and creating a cold chain for transport to rural areas. This vaccine should be modified to give protection against more HPV types and must be cheaper and easier to administer.

Experts say though this vaccine may be effective for prevention of infection a better promising approach for developing countries would be to undergo a cheaper screening test and visual inspection followed by prevention and treatment.


'"/>




Page: 1

Related medicine news :

1. Human Genome Project Achieves Technological Triumph
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Human gene number increases
4. Scientists found ancient Human Germ Killer
5. New standards for Human Research Safety
6. Human wasting disease linked to a gene
7. The Human Mad Cow Case
8. Human Growth Hormone Found To be Dangerous For Human Use
9. Human Antibody That Can Block SARS
10. Human immunity system can battle HIV.
11. The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Two New Human Papilloma virus HPV vaccines prevent cervical cancer

(Date:5/26/2015)... San Diego, CA (PRWEB) May 26, 2015 ... medical director, launched and directed a hospital-wide Patient Blood ... in Bangor that reduced overall blood usage by more ... five-year period. , Covered in detail in an ... PBM program resulted in substantially reduced perioperative red cell ...
(Date:5/26/2015)... CO (PRWEB) May 26, 2015 It ... diverse community foundation in Colorado. On Wednesday, May 13, ... ushered in a new era of community-based giving with ... Titled “Our Future in the Making,” the event celebrated ... The Denver Foundation to mobilize resources for good. , ...
(Date:5/26/2015)... Relias Learning , the leader in online ... services market, announces expansion of their user group sessions ... participation in 2014, they will double the number of ... an exciting new facelift. , Regional user group ... best practices, share their expertise, provide feedback directly to ...
(Date:5/26/2015)... 26, 2015 CIO Review has chosen ... Pharma and Life Sciences Technology Solution Providers. The positioning is ... compliant solution which is applicable across the entire security spectrum ... for broad adoption. , “SIGNiX has been on our ... Pharma and Life Sciences Technology space, and we are happy ...
(Date:5/26/2015)... Indosoft, Inc ., developer of ... DMi Partners contact center to Q-Suite 5.8 call ... contact center ACD system to drop Asterisk 1.4 support. ... trunk features as diversion headers, added Lyra support via ... to warm transfers to improve information handling ...
Breaking Medicine News(10 mins):Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 3Health News:Celebrating "Our Future in the Making" 2Health News:Celebrating "Our Future in the Making" 3Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 2Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 3Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3
... , CRANBURY, N.J., Sept. 10 Amicus ... and chief executive officer, John F. Crowley, will be presenting at the ... scheduled to begin on Monday, September 14 at 5:05 p.m. EDT. , ... the presentation by logging on to the Investors section of the Amicus ...
... Sept. 10 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: ... global life sciences markets, today reported financial results for the three-month ... million, a net loss of $62 million and a loss per ... $252 million in total revenue, a net loss of $10 million ...
... , , CAMBRIDGE, ... ISIS ) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ... Office (USPTO) has allowed an Isis patent application that further expands ... patent broadly covers methods of cleaving a target RNA via a ...
... , , , ST. ... ) announced that Novation, the leading health care supply contracting ... systems to its capital products contract portfolio. This is ... robotic interventional technology among Novation,s capital products offerings. This ...
... , SAN DIEGO, Sept. 10 The American ... to educate individuals and couples about their family-building options in a ... 21st. Those who attend Dessert & Learn La Jolla ... Law, about third party reproduction options like egg donation, sperm donation, ...
... (OTCBB: GVBP.OB) - GENova Biotherapeutics, Inc., ("GENova"), a biotechnology ... that disrupt the advance of life-threatening diseases, today announced ... drug target that combats breast cancer. , The target, ... death in breast cancer cells, thus curtailing development of ...
Cached Medicine News:Health News:MDS Reports Third Quarter 2009 Financial Results 2Health News:MDS Reports Third Quarter 2009 Financial Results 3Health News:MDS Reports Third Quarter 2009 Financial Results 4Health News:MDS Reports Third Quarter 2009 Financial Results 5Health News:MDS Reports Third Quarter 2009 Financial Results 6Health News:MDS Reports Third Quarter 2009 Financial Results 7Health News:MDS Reports Third Quarter 2009 Financial Results 8Health News:MDS Reports Third Quarter 2009 Financial Results 9Health News:MDS Reports Third Quarter 2009 Financial Results 10Health News:MDS Reports Third Quarter 2009 Financial Results 11Health News:MDS Reports Third Quarter 2009 Financial Results 12Health News:MDS Reports Third Quarter 2009 Financial Results 13Health News:MDS Reports Third Quarter 2009 Financial Results 14Health News:MDS Reports Third Quarter 2009 Financial Results 15Health News:MDS Reports Third Quarter 2009 Financial Results 16Health News:MDS Reports Third Quarter 2009 Financial Results 17Health News:MDS Reports Third Quarter 2009 Financial Results 18Health News:MDS Reports Third Quarter 2009 Financial Results 19Health News:MDS Reports Third Quarter 2009 Financial Results 20Health News:MDS Reports Third Quarter 2009 Financial Results 21Health News:MDS Reports Third Quarter 2009 Financial Results 22Health News:MDS Reports Third Quarter 2009 Financial Results 23Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 2Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 3Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 4Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 5Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 6Health News:Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology 2Health News:Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology 3Health News:Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology 4Health News:Innovative Program Educates Hopeful Parents on Third Party Reproduction 2Health News:Innovative Program Educates Hopeful Parents on Third Party Reproduction 3Health News:GENova files patent for new breast cancer treatment 2
(Date:5/26/2015)... May 26, 2015 Boston Scientific Corporation (NYSE: ... 36 th Annual Global Healthcare Conference on June 9 ... Dan Brennan , executive vice president and chief ... Relations, will participate in a 35-minute question and answer session ... 10 a.m. PT. A live webcast of the ...
(Date:5/26/2015)... 2015 Xencor, Inc. (NASDAQ: XNCR ), ... the treatment of autoimmune diseases, asthma and allergic diseases, ... President and Chief Executive Officer, will present at the ... at 8:30 a.m. ET in New York ... of the presentation will be available on the "Events ...
(Date:5/26/2015)... 26, 2015  Northstar Global Business Services, Inc. ... a deal with Mr. Checkout, a national distribution ... product, SNORenz to brick and mortar retail stores. ... cross section of about fifty convenience stores, pharmacies, ... valuable statistics during the lead time the company ...
Breaking Medicine Technology:Boston Scientific To Participate In The Goldman Sachs 36th Annual Global Healthcare Conference 2Xencor to Present at Jefferies 2015 Healthcare Conference 2Northstar announces in-store rollout deal with national distribution group reaching more than 35,000 stores nationwide 2Northstar announces in-store rollout deal with national distribution group reaching more than 35,000 stores nationwide 3
... Nev., June 6, 2011 PDL BioPharma, Inc. (PDL) (NASDAQ: ... for: The 2.00% Convertible Senior Notes due February ... 2.875% Convertible Senior Notes due February 15, 2015 (the 2015 Notes), ... due May 1, 2015 (the May 2015 Notes), effective June 6, ...
... 2011 Sanofi (EURONEXT: SAN and NYSE: ... REGN ) today announced that data showing that the ... significantly improved survival in previously treated metastatic colorectal cancer ... on Gastrointestinal Cancer on June 25, 2011.  The abstract ...
Cached Medicine Technology:PDL BioPharma Announces Conversion Rate Adjustments for its Convertible Notes 2ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients 2ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients 3ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients 4ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients 5ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients 6ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients 7
Inquire...
Inquire...
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Inquire...
Medicine Products: